Colorectal cancer screening is about to reach more Americans, thanks to a major expansion between Exact Sciences and Humana. Beginning August 2025, the next-gen Cologuard Plus™ test will be offered as an in-network benefit for Humana’s 5.8 million Medicare Advantage members—bringing a powerful at-home screening tool to the national stage.
Cologuard Plus, launched just months ago, builds on the original Cologuard’s success with improved accuracy, new biomarkers, and a 40% reduction in false positives. That means fewer unnecessary colonoscopies—and more confidence from the comfort of home.
With FDA approval, Medicare coverage, and inclusion in national guidelines, Cologuard Plus is positioning itself not just as a test—but as a new standard.